Healthcare Yesterday 05:16 PM (GMT+8) · EqualOcean
Yiouda health news on April 18. Recently, molecular mind, an AI protein design platform company, completed tens of millions of dollars of angel round financing, led by Sequoia China, followed by Baidu venture capital, life park venture capital fund, core aviation capital and future Qichuang. This round of financing will be used to further expand the continuous evolution of the team and AI protein platform, as well as the product transformation of scientific research achievements. Molecular heart was founded by Xu Jinbo, Professor of Toyota Institute of computing technology in Chicago and visiting professor of biopic at Peking University. He has studied “Ai protein folding technology” for many years. The raptorx contact method developed in 2016 proved for the first time that deep learning can greatly improve the accuracy of protein structure prediction; In 2020, deepmind applied this method to the development of alphafold and made outstanding contributions to solving the problem of protein prediction. Based on Xu Jinbo’s scientific research achievements, molecular heart continued to develop “Ai protein prediction and design”, and independently developed the AI macromolecule optimization and design platform “moleculeos”, which uses the data-driven deep learning method to help biotechnology experts identify and generate proteins, so as to project the laboratory research results to industrial applications on a large scale. This platform can be used not only for the research and design of peptides, antibodies, enzymes and small proteins, but also for protein optimization and design in the fields of chemistry, materials, industry, agriculture and so on.
This text is a result of machine translation.